Showing results (11-20 of 139) with videos related to
Sort By:
Pageof 14
Current Allergy and Asthma Reports|January 25, 2003
Immunopharmacology of hypersensitivity reactions to drugsDean J Naisbitt, Munir Pirmohamed, B Kevin ParkExpert Opinion on Drug Safety|March 21, 2007
Immunological principles of T-cell-mediated adverse drug reactions in skinDean J Naisbitt, Munir Pirmohamed, B Kevin ParkThe Journal of Allergy and Clinical Immunology|March 1, 2011
Immune pathomechanism of drug hypersensitivity reactionsWerner J Pichler, Dean J Naisbitt, B Kevin ParkThe AAPS Journal|April 6, 2006
Role of bioactivation in drug-induced hypersensitivity reactionsJoseph P Sanderson, Dean J Naisbitt, B Kevin ParkImmunology and Allergy Clinics of North America|July 15, 2014
In vitro diagnosis of delayed-type drug hypersensitivity: mechanistic aspects and unmet needsDean J Naisbitt, Ryan G Nattrass, Monday O OgeseToxicology Letters|December 12, 2022
Activation of tolvaptan-responsive T-cell clones with the structurally-related mozavaptanSean Hammond, Xiaoli Meng, Merrie Mosedale, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 20, 2024
Pathomechanism of Adverse Reactions to Biological Treatment of Inflammatory Skin ConditionsLichen Li, Dean J Naisbitt, Yonghu Sun, et al.Chemical Research in Toxicology|June 24, 2024
Immunological Drug-Drug Interactions Affect the Efficacy and Safety of Immune Checkpoint Inhibitor TherapiesSophie Grice, Anna Olsson-Brown, Dean J Naisbitt, et al.Expert Opinion on Drug Metabolism & Toxicology|December 16, 2014
Are drug metabolites able to cause T-cell-mediated hypersensitivity reactions?Andrew Sullivan, Andrew Gibson, Brian Kevin Park, et al.Toxicology|December 31, 2002
The danger hypothesis--potential role in idiosyncratic drug reactionsMunir Pirmohamed, Dean J Naisbitt, Fraser Gordon, et al.Pageof 14